Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis depends on the increase of fibrosis, whose progression is twice as rapid in men as in women. Aim of the study was to evaluate the effects of reproductive stage on fibrosis severity in women and to compare these findings with age-matched men.A retrospective study of 710 consecutive patients with biopsy-proven chronic hepatitis C was conducted, using data from a clinical database of two tertiary Italian care centers. Four age-matched groups of men served as controls. Data about demographics, biochemistry, liver biopsy and ultrasonography were analyzed. Contributing factors were assessed by multivariate logistic regression analysis.Liver fibrosis...
pp. 191A-1144A of this free journal suppl. entitled: AASLD AbstractsBACKGROUND/AIM: Estrogens inhibi...
OBJECTIVE: The natural course of chronic hepatitis C varies widely. To improve the profiling of pati...
The natural course of chronic hepatitis C varies widely. To improve the profiling of patients at ris...
Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis d...
INTRODUCTION: Chronic hepatitis C is the main cause of death in patients with end-stage liver disea...
Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis d...
Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and menopausal women than ...
BACKGROUND & AIMS:Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and meno...
fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and stea...
Chronic liver disease progresses at unequal rates in the 2 sexes both in viral hepatitis and in live...
The liver, although not a classical target for estrogens, is sensitive to their effects, particularl...
Background/Aims: Progression of chronic hepatitis C depends on the host and viral characteristics, d...
The main injury caused by hepatitis C virus is the hepatic fibrosis, as a result of a chronic inflam...
Chronic hepatitis C (CHC) course revealed differences between men and women. Male gender and postmen...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
pp. 191A-1144A of this free journal suppl. entitled: AASLD AbstractsBACKGROUND/AIM: Estrogens inhibi...
OBJECTIVE: The natural course of chronic hepatitis C varies widely. To improve the profiling of pati...
The natural course of chronic hepatitis C varies widely. To improve the profiling of patients at ris...
Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis d...
INTRODUCTION: Chronic hepatitis C is the main cause of death in patients with end-stage liver disea...
Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis d...
Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and menopausal women than ...
BACKGROUND & AIMS:Chronic hepatitis C (CHC) and liver fibrosis progress more rapidly in men and meno...
fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and stea...
Chronic liver disease progresses at unequal rates in the 2 sexes both in viral hepatitis and in live...
The liver, although not a classical target for estrogens, is sensitive to their effects, particularl...
Background/Aims: Progression of chronic hepatitis C depends on the host and viral characteristics, d...
The main injury caused by hepatitis C virus is the hepatic fibrosis, as a result of a chronic inflam...
Chronic hepatitis C (CHC) course revealed differences between men and women. Male gender and postmen...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
pp. 191A-1144A of this free journal suppl. entitled: AASLD AbstractsBACKGROUND/AIM: Estrogens inhibi...
OBJECTIVE: The natural course of chronic hepatitis C varies widely. To improve the profiling of pati...
The natural course of chronic hepatitis C varies widely. To improve the profiling of patients at ris...